Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jan 24, 2026

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Photocontrollable mononegaviruses.

Maino Tahara¹, Yuto Takishima², Shohei Miyamoto²

¹Department of Virology 3, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.

Proceedings of the National Academy of Sciences of the United States of America

|May 30, 2019

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gene Therapy for Malignant Tumors: Focused on Immunostimulatory Oncolytic Coxsackievirus A11 (CVA11).

Anticancer research·2026

Same author

Less Invasive Light Irradiation Methods for Inner Ear Gene Therapy Based on Photoswitch Technology: Toward Clinical Translation.

Human gene therapy·2026

Same author

A chemically inducible, leakless Cre recombinase by split-protein-based efficient and enhanced degradation (SPEED).

Communications biology·2025

Same author

Paramyxovirus matrix protein redirects METTL3 for dual regulation of viral replication and immune evasion.

PLoS pathogens·2025

Same author

Cord Blood RSV-Neutralizing Antibodies and Risk of Hospitalization for RSV-Associated Acute Respiratory Infection in Vietnamese Children: A Case-Cohort Study.

Vaccines·2025

Same author

AlphaFold3-guided optimization of a photoactivatable endonuclease for top-down genome engineering.

The Journal of biological chemistry·2025

Researchers created photocontrollable mononegaviruses using Magnet proteins. These viruses, including measles and rabies, exhibit oncolytic and gene delivery potential, activated by blue light.

Area of Science:

Virology
Biotechnology
Gene Therapy

Background:

Mononegaviruses show potential as oncolytic and gene delivery vectors.
Controlling viral activity is crucial for therapeutic applications.

Purpose of the Study:

To develop photocontrollable mononegaviruses for enhanced therapeutic applications.
To investigate the use of Magnet proteins for light-inducible viral activity.

Main Methods:

Engineered measles and rabies viruses by incorporating Magnet proteins into the viral polymerase.
Utilized blue light illumination to control the heterodimerization of Magnet proteins and activate viral polymerase.

Main Results:

Generated photocontrollable mononegaviruses (measles and rabies) with light-dependent activity.

Keywords:

measles virus mononegavirus oncolytic rabies virus vector

Related Experiment Videos

Last Updated: Jan 24, 2026

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Demonstrated that viral replication and oncolytic activity were strictly dependent on blue light-induced polymerase activation.

Conclusions:

Photocontrollable mononegaviruses offer a novel strategy for precise spatial and temporal control in gene therapy and oncolytic virotherapy.
Magnet protein-mediated light activation provides a promising platform for developing safer and more effective viral vector systems.